Literature DB >> 33527812

Ethambutol Optic Neuropathy: Vigilance and Screening, the Keys to Prevent Blindness with the Revised Anti-tuberculous Therapy Regimen.

Rohit Saxena1, Swati Phuljhele2, Anupam Prakash3, Rakesh Lodha4, Digvijay Singh5, Satya Karna6, Anant Mohan7, Rashmin Gandhi8, Vimla Menon9, Rajiv Garg10.   

Abstract

There has been change in the guidelines for the management of tuberculosis in India. The new guidelines advocate the daily use of Ethambutol for both intensive and continuation phase of the treatment. This may be a matter of concern as increased cumulative dose may lead to increase in incidence of toxic optic neuropathy due to ethambutol. Indian Neuro-Ophthalmology Society has taken cognizance of the issue and has come-up with guidelines for prevention and early detection of the toxic optic neuropathy. © Journal of the Association of Physicians of India 2011.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 33527812

Source DB:  PubMed          Journal:  J Assoc Physicians India        ISSN: 0004-5772


  3 in total

1.  Response to comment on: Ethambutol toxicity: Expert panel consensus for the primary prevention, diagnosis, and management of ethambutol-induced optic neuropathy.

Authors:  Rohit Saxena; Digvijay Singh; Swati Phuljhele; V Kalaiselvan; Satya Karna; Rashmin Gandhi; Anupam Prakash; Rakesh Lodha; Anant Mohan; Vimla Menon; Rajeev Garg
Journal:  Indian J Ophthalmol       Date:  2022-03       Impact factor: 1.848

2.  Delayed and reversible ethambutol optic neuropathy.

Authors:  Elizabeth Peterson; Eman Hawy
Journal:  Am J Ophthalmol Case Rep       Date:  2022-06-11

3.  Ethambutol toxicity: Expert panel consensus for the primary prevention, diagnosis and management of ethambutol-induced optic neuropathy.

Authors:  Rohit Saxena; Digvijay Singh; Swati Phuljhele; V Kalaiselvan; Satya Karna; Rashmin Gandhi; Anupam Prakash; Rakesh Lodha; Anant Mohan; Vimla Menon; Rajeev Garg
Journal:  Indian J Ophthalmol       Date:  2021-12       Impact factor: 1.848

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.